US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Cadrenal Therapeutics, Inc.

1.51

-0.2400-13.71%

Volume:657.43K

Turnover:980.49K

Market Cap:5.39M

PE:-0.31

High:1.58

Open:1.49

Low:1.42

Close:1.75

52wk High:14.64

52wk Low:1.42

Shares:3.57M

Float Shares:3.22M

Volume Ratio:0.20

T/O Rate:20.40%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-4.8667

EPS(LYR):-6.6394

ROE:-275.16%

ROA:-125.93%

PB:1.32

PE(LYR):-0.23

Loading ...

Overview Company News Filings

Cadrenal Therapeutics - to Initiate Phase 2a Trial of CAD-1005 for Aki in Cardiac Surgery Patients

THOMSON REUTERS

Cadrenal Therapeutics - Phase 2a Trial Expected to Begin Later This Year

THOMSON REUTERS

Cadrenal Therapeutics CEO Quang X. Pham disposes of $90,610 common shares

Cadrenal CEO, Chairman Quang X. Pham sells USD 36,071 of common shares

BRIEF-Cadrenal Therapeutics Says Matthew Szot Steps Down As CFO - SEC Filing

Cadrenal Therapeutics - Appoints Quang X. Pham as Interim CFO and Interim Principal Accounting Officer - SEC Filing

THOMSON REUTERS

Cadrenal Therapeutics - Matthew K. Szot Steps Down as CFO Effective May 28, 2026 - SEC Filing

THOMSON REUTERS

Cadrenal Therapeutics names CEO Quang X. Pham interim CFO after Matthew Szot exit

Cadrenal Therapeutics to attend BIO International Convention 2026 partnering event

Cadrenal Therapeutics CEO, Chairman Quang X. Pham sells USD 3,057.57 in common shares

Cadrenal Therapeutics CEO, Chairman Quang X. Pham sells USD 69,363 of common shares

Cadrenal Therapeutics CEO, Chairman Quang Pham sells 1,165 common shares for $6,628.85

Cadrenal Therapeutics to present at Lytham Partners Spring 2026 Investor Conference

Cadrenal Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary

Press Release: Cadrenal Therapeutics Reports First Quarter 2026 Financial Results and Provides Phase 3 Development Update on CAD-1005 Following End-of-Phase 2 Meeting with FDA

Cadrenal Therapeutics Inc expected to post a loss of $1.62 a share - Earnings Preview

Analysts’ Top Healthcare Picks: Pacira Pharmaceuticals (PCRX), Cadrenal Therapeutics, Inc. (CVKD)

Cadrenal Therapeutics completes CAD-1005 End-of-Phase 2 meeting with FDA

Cadrenal plans pivotal Phase 3 trial of CAD-1005 in heparin-induced thrombocytopenia

Cadrenal Therapeutics Inc - FDA Provides Guidance for Phase 3 Advancement of CAD-1005 in Hit

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigeractivity.com/stock/CVKD/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CVKD","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CVKD\",,,,,undefined,":{"symbol":"CVKD","market":"US","secType":"STK","nameCN":"Cadrenal Therapeutics, Inc.","latestPrice":1.51,"timestamp":1788287280430,"preClose":1.75,"halted":0,"volume":657432,"delay":0,"changeRate":-0.13714285714285715,"floatShares":3223023,"shares":3567600,"eps":-4.866724,"marketStatus":"Trading","change":-0.24,"latestTime":"09-01 14:28:17 EDT","open":1.49,"high":1.58,"low":1.42,"amount":980490.5346672001,"amplitude":0.091429,"askPrice":1.55,"askSize":253,"bidPrice":1.46,"bidSize":100,"shortable":0,"etf":0,"ttmEps":-4.866724,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1788292800000},"marketStatusCode":2,"adr":0,"listingDate":1674190800000,"exchange":"NASDAQ","adjPreClose":1.75,"preHourTrading":{"tag":"盘前","latestPrice":1.49,"preClose":1.75,"latestTime":"09:28 EDT","volume":111783,"amount":162545.6500374,"timestamp":1788269283019,"change":-0.26,"changeRate":-0.148571,"amplitude":0.119657},"postHourTrading":{"tag":"盘后","latestPrice":1.47,"preClose":1.75,"latestTime":"19:59 EDT","volume":485074,"amount":776785.9359,"timestamp":1788220799232,"change":-0.28,"changeRate":-0.16,"amplitude":0.188629},"volumeRatio":0.197198},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CVKD\",,,,,undefined,":{"symbol":"CVKD","floatShares":3223023,"roa":"-125.93%","roe":"-275.16%","lyrEps":-6.639405,"volumeRatio":0.197198,"shares":3567600,"dividePrice":0,"high":1.58,"amplitude":0.091429,"preClose":1.75,"low":1.42,"week52Low":1.42,"pbRate":"1.32","week52High":14.64,"institutionHeld":0,"latestPrice":1.51,"committee":-0.433428,"eps":-4.866724,"divideRate":0,"volume":657432,"delay":0,"ttmEps":-4.866724,"open":1.49,"prevYearClose":6.78,"prevWeekClose":1.54,"prevMonthClose":1.75,"prevQuarterClose":3.34,"fiveDayClose":1.53,"twentyDayClose":2.03,"sixtyDayClose":4.44},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CVKD\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-13","symbol":"CVKD","fiscalQuarterEnding":"2026/06","expectedEps":-1.16,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1786593600000,"reportTimeType":"post","actualEps":-1.14},{"market":"US","date":"2026-05-07","symbol":"CVKD","fiscalQuarterEnding":"2026/03","expectedEps":-1.51,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1778126400000,"reportTimeType":"pre","actualEps":-1.04},{"market":"US","date":"2026-03-31","symbol":"CVKD","fiscalQuarterEnding":"2025/12","expectedEps":-1.17,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1774929600000,"reportTimeType":"pre","actualEps":-1.41},{"market":"US","date":"2025-11-10","symbol":"CVKD","fiscalQuarterEnding":"2025/09","expectedEps":-1.55,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1762750800000,"reportTimeType":"pre","actualEps":-1.31},{"market":"US","date":"2025-08-11","symbol":"CVKD","fiscalQuarterEnding":"2025/06","expectedEps":-1.6,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1754884800000,"reportTimeType":"pre","actualEps":-1.87}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CVKD\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CVKD\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":2,"updateTime":1775793600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/CVKD\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"CVKD","date":"2026-08-28","current":-0.359585,"percent":0.961009,"low":-6.5442,"twenty":-2.498975,"median":-1.454925,"eighty":-0.838248,"high":-0.407485,"avg":-1.765605,"sd":1.08517,"marketCap":5583281},"quantilePoints":[{"date":"2023-01-20","current":-6.5442,"twenty":-6.16384,"median":-5.593301,"eighty":-5.593301,"marketCap":47934449},{"date":"2023-01-27","current":-4.161603,"twenty":-5.973233,"median":-5.338088,"eighty":-4.549173,"marketCap":30482586},{"date":"2023-02-03","current":-3.812156,"twenty":-5.593301,"median":-4.511051,"eighty":-4.113951,"marketCap":27922980},{"date":"2023-02-10","current":-3.160912,"twenty":-5.38913,"median":-4.288675,"eighty":-3.488122,"marketCap":23152804},{"date":"2023-02-17","current":-3.573896,"twenty":-4.892266,"median":-4.082183,"eighty":-3.392818,"marketCap":26177793},{"date":"2023-02-24","current":-3.345166,"twenty":-4.587294,"median":-3.573896,"eighty":-3.380111,"marketCap":24502414},{"date":"2023-03-03","current":-2.875001,"twenty":-4.507652,"median":-3.569925,"eighty":-3.160912,"marketCap":21058580},{"date":"2023-03-10","current":-2.589089,"twenty":-4.478393,"median":-3.494476,"eighty":-3.058111,"marketCap":18964357},{"date":"2023-03-17","current":-2.271409,"twenty":-4.364918,"median":-3.399172,"eighty":-2.900415,"marketCap":16637442},{"date":"2023-03-24","current":-1.985498,"twenty":-4.145719,"median":-3.271465,"eighty":-2.525553,"marketCap":14543218},{"date":"2023-03-31","current":-2.239641,"twenty":-4.082183,"median":-3.15297,"eighty":-2.291105,"marketCap":16404750},{"date":"2023-04-06","current":-2.112569,"twenty":-4.082183,"median":-3.137086,"eighty":-2.249171,"marketCap":15473984},{"date":"2023-04-12","current":-2.229793,"twenty":-4.028178,"median":-3.11326,"eighty":-2.242818,"marketCap":16332616},{"date":"2023-04-21","current":-2.446133,"twenty":-3.866161,"median":-3.03114,"eighty":-2.237671,"marketCap":17917245},{"date":"2023-04-28","current":-2.366713,"twenty":-3.6692,"median":-2.946479,"eighty":-2.249171,"marketCap":17335516},{"date":"2023-05-05","current":-2.096686,"twenty":-3.573896,"median":-2.875001,"eighty":-2.188781,"marketCap":15357639},{"date":"2023-05-12","current":-1.444685,"twenty":-3.573896,"median":-2.612915,"eighty":-2.169752,"marketCap":17800899},{"date":"2023-05-19","current":-1.359704,"twenty":-3.569131,"median":-2.462017,"eighty":-2.077625,"marketCap":16753788},{"date":"2023-05-26","current":-1.284383,"twenty":-3.546035,"median":-2.446133,"eighty":-1.985498,"marketCap":15825717},{"date":"2023-06-02","current":-1.346224,"twenty":-3.517444,"median":-2.384186,"eighty":-1.928316,"marketCap":16587696},{"date":"2023-06-09","current":-1.503204,"twenty":-3.469062,"median":-2.334945,"eighty":-1.45944,"marketCap":18521951},{"date":"2023-06-16","current":-1.44612,"twenty":-3.43094,"median":-2.283322,"eighty":-1.45944,"marketCap":17818586},{"date":"2023-06-23","current":-1.484176,"twenty":-3.418233,"median":-2.263467,"eighty":-1.465148,"marketCap":18287496},{"date":"2023-06-30","current":-1.398551,"twenty":-3.367404,"median":-2.247583,"eighty":-1.465148,"marketCap":17232448},{"date":"2023-07-07","current":-1.417578,"twenty":-3.349614,"median":-2.226775,"eighty":-1.445833,"marketCap":17466903},{"date":"2023-07-14","current":-1.503299,"twenty":-3.286205,"median":-2.191989,"eighty":-1.443298,"marketCap":18523123},{"date":"2023-07-21","current":-1.637011,"twenty":-3.183023,"median":-2.150431,"eighty":-1.445833,"marketCap":20170670},{"date":"2023-07-28","current":-1.152922,"twenty":-3.160912,"median":-2.112569,"eighty":-1.436606,"marketCap":14205899},{"date":"2023-08-04","current":-1.14188,"twenty":-3.148205,"median":-2.045063,"eighty":-1.406161,"marketCap":14069843},{"date":"2023-08-11","current":-0.924489,"twenty":-3.132321,"median":-1.985498,"eighty":-1.379336,"marketCap":11854271},{"date":"2023-08-18","current":-0.791165,"twenty":-3.116437,"median":-1.961672,"eighty":-1.351057,"marketCap":10144725},{"date":"2023-08-25","current":-0.756633,"twenty":-3.058111,"median":-1.906237,"eighty":-1.33893,"marketCap":9701938},{"date":"2023-09-01","current":-0.782025,"twenty":-3.028503,"median":-1.714964,"eighty":-1.314525,"marketCap":10027520},{"date":"2023-09-08","current":-0.93325,"twenty":-2.992542,"median":-1.675857,"eighty":-1.277692,"marketCap":11966608},{"date":"2023-09-15","current":-0.791064,"twenty":-2.948067,"median":-1.596605,"eighty":-1.146297,"marketCap":10143423},{"date":"2023-09-22","current":-0.685541,"twenty":-2.919476,"median":-1.522232,"eighty":-1.104853,"marketCap":8790358},{"date":"2023-09-29","current":-0.680463,"twenty":-2.884531,"median":-1.503251,"eighty":-0.944749,"marketCap":8725245},{"date":"2023-10-06","current":-0.665229,"twenty":-2.792404,"median":-1.503204,"eighty":-0.904366,"marketCap":8529903},{"date":"2023-10-13","current":-0.649081,"twenty":-2.655802,"median":-1.479419,"eighty":-0.871399,"marketCap":8322842},{"date":"2023-10-20","current":-0.597183,"twenty":-2.61768,"median":-1.473616,"eighty":-0.791104,"marketCap":7657379},{"date":"2023-10-27","current":-0.503746,"twenty":-2.598619,"median":-1.465148,"eighty":-0.784463,"marketCap":6459285},{"date":"2023-11-03","current":-0.446871,"twenty":-2.525553,"median":-1.450877,"eighty":-0.769227,"marketCap":5730011},{"date":"2023-11-10","current":-0.446511,"twenty":-2.471547,"median":-1.444685,"eighty":-0.749525,"marketCap":5730011},{"date":"2023-11-17","current":-0.457674,"twenty":-2.462017,"median":-1.436606,"eighty":-0.722103,"marketCap":5873262},{"date":"2023-11-22","current":-0.507704,"twenty":-2.455663,"median":-1.417578,"eighty":-0.721088,"marketCap":6515283},{"date":"2023-12-01","current":-0.466807,"twenty":-2.446133,"median":-1.403307,"eighty":-0.699922,"marketCap":5990466},{"date":"2023-12-08","current":-0.471881,"twenty":-2.427072,"median":-1.388031,"eighty":-0.680463,"marketCap":6055580},{"date":"2023-12-15","current":-0.559052,"twenty":-2.387045,"median":-1.376708,"eighty":-0.648167,"marketCap":7174222},{"date":"2023-12-22","current":-0.56514,"twenty":-2.368619,"median":-1.351076,"eighty":-0.63015,"marketCap":7252358},{"date":"2023-12-29","current":-0.722638,"twenty":-2.366713,"median":-1.348603,"eighty":-0.629682,"marketCap":9273503},{"date":"2024-01-05","current":-0.635264,"twenty":-2.347652,"median":-1.341467,"eighty":-0.629743,"marketCap":8152244},{"date":"2024-01-12","current":-0.620651,"twenty":-2.315884,"median":-1.326907,"eighty":-0.629682,"marketCap":7964716},{"date":"2024-01-19","current":-0.953911,"twenty":-2.296823,"median":-1.312673,"eighty":-0.629723,"marketCap":12241388},{"date":"2024-01-26","current":-1.319238,"twenty":-2.284116,"median":-1.293897,"eighty":-0.63015,"marketCap":16929580},{"date":"2024-02-02","current":-1.430866,"twenty":-2.276174,"median":-1.320586,"eighty":-0.632524,"marketCap":18362083},{"date":"2024-02-09","current":-0.923467,"twenty":-2.265055,"median":-1.321934,"eighty":-0.637094,"marketCap":11850706},{"date":"2024-02-16","current":-0.791644,"twenty":-2.255525,"median":-1.298654,"eighty":-0.640854,"marketCap":10159050},{"date":"2024-02-23","current":-0.743847,"twenty":-2.252348,"median":-1.278807,"eighty":-0.643003,"marketCap":9545678},{"date":"2024-03-01","current":-0.714418,"twenty":-2.237671,"median":-1.221262,"eighty":-0.639426,"marketCap":9168018},{"date":"2024-03-08","current":-0.654241,"twenty":-2.228586,"median":-1.149822,"eighty":-0.640346,"marketCap":8395769},{"date":"2024-03-15","current":-1.139373,"twenty":-2.218452,"median":-1.14188,"eighty":-0.642618,"marketCap":9521837},{"date":"2024-03-22","current":-1.2068,"twenty":-2.196183,"median":-1.140626,"eighty":-0.643971,"marketCap":10085335},{"date":"2024-03-28","current":-1.225937,"twenty":-2.191989,"median":-1.148028,"eighty":-0.645513,"marketCap":10245260},{"date":"2024-04-05","current":-1.16485,"twenty":-2.176105,"median":-1.152922,"eighty":-0.647557,"marketCap":9734749},{"date":"2024-04-12","current":-0.835183,"twenty":-2.160222,"median":-1.146113,"eighty":-0.649081,"marketCap":6979692},{"date":"2024-04-19","current":-0.823306,"twenty":-2.140639,"median":-1.139373,"eighty":-0.654241,"marketCap":6880439},{"date":"2024-04-26","current":-0.81143,"twenty":-2.128453,"median":-1.124432,"eighty":-0.658604,"marketCap":6781187},{"date":"2024-05-03","current":-0.890734,"twenty":-2.112569,"median":-1.111003,"eighty":-0.664084,"marketCap":7443938},{"date":"2024-05-10","current":-0.929811,"twenty":-2.096686,"median":-1.0981,"eighty":-0.664287,"marketCap":7770510},{"date":"2024-05-17","current":-1.420575,"twenty":-2.049034,"median":-1.111003,"eighty":-0.665229,"marketCap":6885242},{"date":"2024-05-24","current":-1.383913,"twenty":-2.041092,"median":-1.124432,"eighty":-0.669767,"marketCap":6707548},{"date":"2024-05-31","current":-1.354187,"twenty":-2.034738,"median":-1.135559,"eighty":-0.672852,"marketCap":6563472},{"date":"2024-06-07","current":-1.651117,"twenty":-1.995028,"median":-1.145503,"eighty":-0.674597,"marketCap":8002633},{"date":"2024-06-14","current":-1.462522,"twenty":-1.985498,"median":-1.149334,"eighty":-0.676934,"marketCap":7088550},{"date":"2024-06-21","current":-1.516029,"twenty":-1.985498,"median":-1.156171,"eighty":-0.679183,"marketCap":7347887},{"date":"2024-06-28","current":-1.504138,"twenty":-1.985498,"median":-1.16485,"eighty":-0.680036,"marketCap":7290256},{"date":"2024-07-05","current":-1.592623,"twenty":-1.956907,"median":-1.185729,"eighty":-0.680463,"marketCap":7719123},{"date":"2024-07-12","current":-1.549057,"twenty":-1.928316,"median":-1.2068,"eighty":-0.68257,"marketCap":7507971},{"date":"2024-07-15","current":-1.520322,"twenty":-1.925139,"median":-1.2068,"eighty":-0.683272,"marketCap":7368698},{"date":"2024-08-02","current":-1.416942,"twenty":-1.921962,"median":-1.214031,"eighty":-0.683974,"marketCap":6867633},{"date":"2024-08-09","current":-1.111674,"twenty":-1.906237,"median":-1.225937,"eighty":-0.685541,"marketCap":6933267},{"date":"2024-08-16","current":-1.293659,"twenty":-1.846933,"median":-1.234183,"eighty":-0.690721,"marketCap":8068268},{"date":"2024-08-23","current":-1.172164,"twenty":-1.818901,"median":-1.225937,"eighty":-0.699354,"marketCap":7310532},{"date":"2024-08-30","current":-1.264569,"twenty":-1.714964,"median":-1.241521,"eighty":-0.700775,"marketCap":7886837},{"date":"2024-09-06","current":-1.377507,"twenty":-1.706882,"median":-1.245795,"eighty":-0.702272,"marketCap":8591209},{"date":"2024-09-13","current":-1.830972,"twenty":-1.706882,"median":-1.246644,"eighty":-0.711712,"marketCap":11419371},{"date":"2024-09-20","current":-1.918243,"twenty":-1.834164,"median":-1.261146,"eighty":-0.71433,"marketCap":11963659},{"date":"2024-09-27","current":-2.482935,"twenty":-1.908638,"median":-1.273231,"eighty":-0.715692,"marketCap":15485521},{"date":"2024-10-04","current":-1.950755,"twenty":-1.957258,"median":-1.289021,"eighty":-0.720072,"marketCap":12166433},{"date":"2024-10-11","current":-1.928578,"twenty":-1.985498,"median":-1.30307,"eighty":-0.721088,"marketCap":12028120},{"date":"2024-10-18","current":-2.789238,"twenty":-2.037954,"median":-1.318426,"eighty":-0.721575,"marketCap":17395865},{"date":"2024-10-25","current":-2.86453,"twenty":-2.049228,"median":-1.322439,"eighty":-0.722103,"marketCap":17865446},{"date":"2024-10-31","current":-3.933452,"twenty":-2.070731,"median":-1.331376,"eighty":-0.722465,"marketCap":24532076},{"date":"2024-11-08","current":-3.909452,"twenty":-2.133327,"median":-1.338437,"eighty":-0.727802,"marketCap":24382399},{"date":"2024-11-15","current":-3.259855,"twenty":-2.194086,"median":-1.341467,"eighty":-0.734352,"marketCap":24801495},{"date":"2024-11-22","current":-3.282348,"twenty":-2.233732,"median":-1.351028,"eighty":-0.73941,"marketCap":24972628},{"date":"2024-11-29","current":-3.558806,"twenty":-2.265055,"median":-1.353013,"eighty":-0.74173,"marketCap":27075962},{"date":"2024-12-06","current":-3.132405,"twenty":-2.307334,"median":-1.357489,"eighty":-0.742873,"marketCap":23831837},{"date":"2024-12-13","current":-2.717719,"twenty":-2.368619,"median":-1.360113,"eighty":-0.745058,"marketCap":20676837},{"date":"2024-12-20","current":-3.394806,"twenty":-2.438951,"median":-1.363105,"eighty":-0.747693,"marketCap":25828222},{"date":"2024-12-27","current":-3.854006,"twenty":-2.462017,"median":-1.369978,"eighty":-0.749448,"marketCap":29321894},{"date":"2025-01-03","current":-3.631435,"twenty":-2.481224,"median":-1.377507,"eighty":-0.751556,"marketCap":27628533},{"date":"2025-01-10","current":-3.877435,"twenty":-2.523165,"median":-1.379523,"eighty":-0.753182,"marketCap":29500143},{"date":"2025-01-17","current":-4.264007,"twenty":-2.624538,"median":-1.387215,"eighty":-0.756024,"marketCap":32441245},{"date":"2025-01-24","current":-4.636522,"twenty":-2.674136,"median":-1.387903,"eighty":-0.758704,"marketCap":35275397},{"date":"2025-01-31","current":-4.458465,"twenty":-2.840559,"median":-1.398551,"eighty":-0.76167,"marketCap":33920708},{"date":"2025-02-07","current":-4.474865,"twenty":-2.909946,"median":-1.409317,"eighty":-0.766663,"marketCap":34045482},{"date":"2025-02-14","current":-4.49595,"twenty":-2.953876,"median":-1.417578,"eighty":-0.770226,"marketCap":34205906},{"date":"2025-02-21","current":-4.50415,"twenty":-3.001398,"median":-1.420575,"eighty":-0.772831,"marketCap":34268293},{"date":"2025-02-28","current":-4.313207,"twenty":-3.066784,"median":-1.427287,"eighty":-0.777478,"marketCap":32815567},{"date":"2025-03-07","current":-3.912578,"twenty":-3.139979,"median":-1.436606,"eighty":-0.780079,"marketCap":29767516},{"date":"2025-03-14","current":-4.088293,"twenty":-3.197171,"median":-1.445403,"eighty":-0.780934,"marketCap":31104380},{"date":"2025-03-21","current":-3.441281,"twenty":-3.248668,"median":-1.453604,"eighty":-0.782025,"marketCap":36654345},{"date":"2025-03-28","current":-3.301865,"twenty":-3.277995,"median":-1.456931,"eighty":-0.78237,"marketCap":35169374},{"date":"2025-04-04","current":-2.968325,"twenty":-3.266821,"median":-1.464503,"eighty":-0.783762,"marketCap":31616722},{"date":"2025-04-11","current":-2.518311,"twenty":-3.259068,"median":-1.469382,"eighty":-0.787263,"marketCap":26823461},{"date":"2025-04-17","current":-2.85891,"twenty":-3.257859,"median":-1.474662,"eighty":-0.790653,"marketCap":30451302},{"date":"2025-04-25","current":-3.000091,"twenty":-3.257392,"median":-1.49369,"eighty":-0.791084,"marketCap":31955070},{"date":"2025-05-02","current":-2.911853,"twenty":-3.251752,"median":-1.503204,"eighty":-0.791261,"marketCap":31015215},{"date":"2025-05-09","current":-2.270277,"twenty":-3.230283,"median":-1.504138,"eighty":-0.792361,"marketCap":29135505},{"date":"2025-05-16","current":-2.217562,"twenty":-3.211785,"median":-1.51768,"eighty":-0.795364,"marketCap":28458997},{"date":"2025-05-23","current":-2.303286,"twenty":-3.207473,"median":-1.520322,"eighty":-0.798283,"marketCap":29559125},{"date":"2025-05-30","current":-2.048131,"twenty":-3.194675,"median":-1.522232,"eighty":-0.80779,"marketCap":26284611},{"date":"2025-06-06","current":-2.238922,"twenty":-3.17692,"median":-1.535185,"eighty":-0.81143,"marketCap":28733121},{"date":"2025-06-13","current":-2.297156,"twenty":-3.160912,"median":-1.541956,"eighty":-0.811839,"marketCap":29480458},{"date":"2025-06-20","current":-2.051962,"twenty":-3.160912,"median":-1.546017,"eighty":-0.812362,"marketCap":26333778},{"date":"2025-06-27","current":-1.575368,"twenty":-3.148205,"median":-1.553351,"eighty":-0.816087,"marketCap":20217419},{"date":"2025-07-03","current":-1.989132,"twenty":-3.137454,"median":-1.556427,"eighty":-0.819168,"marketCap":25527441},{"date":"2025-07-11","current":-1.992197,"twenty":-3.130448,"median":-1.575368,"eighty":-0.822233,"marketCap":25566775},{"date":"2025-07-18","current":-1.819029,"twenty":-3.122655,"median":-1.585907,"eighty":-0.824111,"marketCap":23344432},{"date":"2025-07-25","current":-1.748536,"twenty":-3.115288,"median":-1.592623,"eighty":-0.830969,"marketCap":22439761},{"date":"2025-08-01","current":-1.596822,"twenty":-3.112066,"median":-1.60755,"eighty":-0.83978,"marketCap":20492753},{"date":"2025-08-08","current":-1.687442,"twenty":-3.09327,"median":-1.615212,"eighty":-0.845488,"marketCap":21655715},{"date":"2025-08-15","current":-1.874525,"twenty":-3.081005,"median":-1.616467,"eighty":-0.850297,"marketCap":26445353},{"date":"2025-08-22","current":-1.806334,"twenty":-3.070504,"median":-1.637011,"eighty":-0.858896,"marketCap":25483332},{"date":"2025-08-29","current":-1.928207,"twenty":-3.05288,"median":-1.651282,"eighty":-0.863774,"marketCap":27202689},{"date":"2025-09-05","current":-1.815039,"twenty":-3.045161,"median":-1.654092,"eighty":-0.866712,"marketCap":25606143},{"date":"2025-09-12","current":-1.958675,"twenty":-3.041134,"median":-1.665783,"eighty":-0.875806,"marketCap":27632529},{"date":"2025-09-19","current":-1.935461,"twenty":-3.028991,"median":-1.685629,"eighty":-0.883586,"marketCap":27305032},{"date":"2025-09-26","current":-2.060236,"twenty":-3.01081,"median":-1.701972,"eighty":-0.884716,"marketCap":29065326},{"date":"2025-10-03","current":-2.058785,"twenty":-2.99162,"median":-1.71336,"eighty":-0.887838,"marketCap":29044858},{"date":"2025-10-10","current":-2.058785,"twenty":-2.977972,"median":-1.730146,"eighty":-0.89028,"marketCap":29044858},{"date":"2025-10-17","current":-2.005828,"twenty":-2.973266,"median":-1.744222,"eighty":-0.89604,"marketCap":28297756},{"date":"2025-10-24","current":-1.997849,"twenty":-2.966913,"median":-1.748536,"eighty":-0.904366,"marketCap":28185179},{"date":"2025-10-31","current":-1.874525,"twenty":-2.963428,"median":-1.767691,"eighty":-0.910735,"marketCap":26445353},{"date":"2025-11-07","current":-1.770062,"twenty":-2.961332,"median":-1.774587,"eighty":-0.921067,"marketCap":24971618},{"date":"2025-11-14","current":-1.657615,"twenty":-2.959148,"median":-1.761439,"eighty":-0.923876,"marketCap":23845849},{"date":"2025-11-21","current":-1.630588,"twenty":-2.955352,"median":-1.753133,"eighty":-0.926618,"marketCap":23457048},{"date":"2025-11-28","current":-1.354629,"twenty":-2.954378,"median":-1.747124,"eighty":-0.930499,"marketCap":19487202},{"date":"2025-12-05","current":-1.601728,"twenty":-2.954068,"median":-1.744222,"eighty":-0.934516,"marketCap":23041879},{"date":"2025-12-12","current":-1.587298,"twenty":-2.950868,"median":-1.73848,"eighty":-0.939656,"marketCap":22834295},{"date":"2025-12-19","current":-1.063489,"twenty":-2.940291,"median":-1.726315,"eighty":-0.940873,"marketCap":15298977},{"date":"2025-12-26","current":-1.063489,"twenty":-2.940291,"median":-1.71823,"eighty":-0.944523,"marketCap":15298977},{"date":"2026-01-02","current":-1.101967,"twenty":-2.938888,"median":-1.708991,"eighty":-0.944976,"marketCap":15852501},{"date":"2026-01-09","current":-1.280752,"twenty":-2.91719,"median":-1.701972,"eighty":-0.952147,"marketCap":18424440},{"date":"2026-01-16","current":-1.332762,"twenty":-2.904794,"median":-1.687875,"eighty":-0.957005,"marketCap":19172641},{"date":"2026-01-23","current":-1.241744,"twenty":-2.899853,"median":-1.679836,"eighty":-0.969272,"marketCap":17863290},{"date":"2026-01-30","current":-1.212489,"twenty":-2.893625,"median":-1.665783,"eighty":-0.98096,"marketCap":17442427},{"date":"2026-02-06","current":-0.867921,"twenty":-2.886524,"median":-1.656007,"eighty":-0.98096,"marketCap":12485598},{"date":"2026-02-13","current":-0.880923,"twenty":-2.881499,"median":-1.651447,"eighty":-0.944863,"marketCap":12672648},{"date":"2026-02-20","current":-1.009324,"twenty":-2.878053,"median":-1.641539,"eighty":-0.941701,"marketCap":14519768},{"date":"2026-02-27","current":-1.362018,"twenty":-2.873859,"median":-1.62773,"eighty":-0.944396,"marketCap":19593504},{"date":"2026-03-06","current":-1.299443,"twenty":-2.8691,"median":-1.617721,"eighty":-0.944749,"marketCap":18693325},{"date":"2026-03-13","current":-1.16698,"twenty":-2.862282,"median":-1.60245,"eighty":-0.948618,"marketCap":16787751},{"date":"2026-03-20","current":-1.132848,"twenty":-2.857498,"median":-1.596822,"eighty":-0.955458,"marketCap":16296745},{"date":"2026-03-27","current":-0.851668,"twenty":-2.854674,"median":-1.589961,"eighty":-0.944749,"marketCap":12251785},{"date":"2026-04-02","current":-0.865491,"twenty":-2.853417,"median":-1.587275,"eighty":-0.939656,"marketCap":11456822},{"date":"2026-04-10","current":-0.941191,"twenty":-2.848599,"median":-1.585719,"eighty":-0.93011,"marketCap":12458880},{"date":"2026-04-17","current":-0.918466,"twenty":-2.823863,"median":-1.582965,"eighty":-0.926432,"marketCap":12158062},{"date":"2026-04-24","current":-1.04724,"twenty":-2.784819,"median":-1.573829,"eighty":-0.927082,"marketCap":13862698},{"date":"2026-05-01","current":-1.551057,"twenty":-2.759024,"median":-1.555271,"eighty":-0.929709,"marketCap":20531907},{"date":"2026-05-08","current":-1.399905,"twenty":-2.724786,"median":-1.551057,"eighty":-0.93011,"marketCap":18531046},{"date":"2026-05-15","current":-1.36454,"twenty":-2.71069,"median":-1.547537,"eighty":-0.931696,"marketCap":16222361},{"date":"2026-05-22","current":-1.338647,"twenty":-2.679763,"median":-1.541956,"eighty":-0.934516,"marketCap":15914536},{"date":"2026-05-29","current":-1.29463,"twenty":-2.668509,"median":-1.537105,"eighty":-0.93958,"marketCap":15391235},{"date":"2026-06-05","current":-1.115971,"twenty":-2.647139,"median":-1.531678,"eighty":-0.939961,"marketCap":13267244},{"date":"2026-06-12","current":-1.043472,"twenty":-2.647139,"median":-1.522232,"eighty":-0.941191,"marketCap":12405335},{"date":"2026-06-18","current":-0.747912,"twenty":-2.638821,"median":-1.519662,"eighty":-0.938314,"marketCap":8891565},{"date":"2026-06-26","current":-0.690009,"twenty":-2.628688,"median":-1.514039,"eighty":-0.929033,"marketCap":8203186},{"date":"2026-07-02","current":-0.7648,"twenty":-2.625072,"median":-1.503718,"eighty":-0.92408,"marketCap":9092342},{"date":"2026-07-10","current":-0.726198,"twenty":-2.614313,"median":-1.503204,"eighty":-0.915436,"marketCap":8633423},{"date":"2026-07-17","current":-0.56214,"twenty":-2.59754,"median":-1.488933,"eighty":-0.902969,"marketCap":6683015},{"date":"2026-07-24","current":-0.489762,"twenty":-2.58972,"median":-1.474662,"eighty":-0.890464,"marketCap":5822541},{"date":"2026-07-31","current":-0.504237,"twenty":-2.586191,"median":-1.473616,"eighty":-0.884716,"marketCap":5994636},{"date":"2026-08-07","current":-0.45116,"twenty":-2.579965,"median":-1.46932,"eighty":-0.880724,"marketCap":5363621},{"date":"2026-08-14","current":-0.448747,"twenty":-2.553613,"median":-1.465148,"eighty":-0.866463,"marketCap":5334939},{"date":"2026-08-21","current":-0.491387,"twenty":-2.514854,"median":-1.460375,"eighty":-0.851932,"marketCap":5672471},{"date":"2026-08-28","current":-0.483661,"twenty":-2.498975,"median":-1.454925,"eighty":-0.838248,"marketCap":5583281}],"updateTime":1788247011599},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CVKD\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2643205803","title":"Cadrenal Therapeutics - to Initiate Phase 2a Trial of CAD-1005 for Aki in Cardiac Surgery Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2643205803","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643205803?lang=en_us&edition=fundamental","pubTime":"2026-06-15 20:30","pubTimestamp":1781526600,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260615:nTUA4YX9YG:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","CVKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643058052","title":"Cadrenal Therapeutics - Phase 2a Trial Expected to Begin Later This Year","url":"https://stock-news.laohu8.com/highlight/detail?id=2643058052","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643058052?lang=en_us&edition=fundamental","pubTime":"2026-06-15 20:30","pubTimestamp":1781526600,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260615:nTUA4YX9YG:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","CVKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642150472","title":"Cadrenal Therapeutics CEO Quang X. Pham disposes of $90,610 common shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2642150472","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642150472?lang=en_us&edition=fundamental","pubTime":"2026-06-11 08:26","pubTimestamp":1781137618,"startTime":"0","endTime":"0","summary":"Cadrenal Therapeutics chairman, CEO, interim CFO Quang X. Pham sold 22,385 common shares on June 8-10.Sales were priced at weighted-average $4.38, $4.06, $4.21.Direct holdings fell to 150,839 shares following the transactions.Separately, he reported 200,000 shares held indirectly through the PVBQ Living Trust.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cadrenal Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 10, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260611:nNDLXWt3m:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Cadrenal Therapeutics CEO Quang X. Pham disposes of $90,610 common shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CVKD","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641128533","title":"Cadrenal CEO, Chairman Quang X. Pham sells USD 36,071 of common shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2641128533","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641128533?lang=en_us&edition=fundamental","pubTime":"2026-06-06 05:27","pubTimestamp":1780694829,"startTime":"0","endTime":"0","summary":"Cadrenal Therapeutics CEO and Chairman Quang X. Pham sold 8,285 common shares in open-market transactions on June 3-5.Sales prices averaged USD 4.26 to USD 4.42 per share.Directly held stake fell to 173,224 shares following the sales.He also reported indirect ownership of 200,000 shares held by The PVBQ Living Trust.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cadrenal Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 05, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260605:nNDL8sZ8ZP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Cadrenal CEO, Chairman Quang X. Pham sells USD 36,071 of common shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CVKD","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640718295","title":"BRIEF-Cadrenal Therapeutics Says Matthew Szot Steps Down As CFO - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2640718295","media":"Reuters","labels":["executive","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640718295?lang=en_us&edition=fundamental","pubTime":"2026-06-04 05:34","pubTimestamp":1780522462,"startTime":"0","endTime":"0","summary":"BRIEF-Cadrenal Therapeutics Says Matthew Szot Steps Down As CFO - SEC FilingJune 3  - Cadrenal Therapeutics Inc CVKD.O:CADRENAL THERAPEUTICS - MATTHEW K. SZOT STEPS DOWN AS CFO EFFECTIVE MAY 28, 2026 - SEC FILINGCADRENAL THERAPEUTICS - APPOINTS QUANG X. PHAM AS INTERIM CFO AND INTERIM PRINCIPAL ACCOUNTING OFFICER - SEC FILINGSource text: [ID:n0001213900-26-064744]Further company coverage: CVKD.O ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260603:nFWN42B0XW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CVKD","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640181470","title":"Cadrenal Therapeutics - Appoints Quang X. Pham as Interim CFO and Interim Principal Accounting Officer - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2640181470","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640181470?lang=en_us&edition=fundamental","pubTime":"2026-06-04 04:26","pubTimestamp":1780518393,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260603:nFWN42B0XW:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","CVKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640181405","title":"Cadrenal Therapeutics - Matthew K. Szot Steps Down as CFO Effective May 28, 2026 - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2640181405","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640181405?lang=en_us&edition=fundamental","pubTime":"2026-06-04 04:26","pubTimestamp":1780518393,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260603:nFWN42B0XW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CVKD","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640218140","title":"Cadrenal Therapeutics names CEO Quang X. Pham interim CFO after Matthew Szot exit","url":"https://stock-news.laohu8.com/highlight/detail?id=2640218140","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640218140?lang=en_us&edition=fundamental","pubTime":"2026-06-04 04:26","pubTimestamp":1780518386,"startTime":"0","endTime":"0","summary":"Cadrenal Therapeutics named CEO Quang X. Pham interim CFO and interim principal accounting officer, effective immediately.Matthew K. Szot stepped down as CFO on May 28, 2026; the company started a search for a permanent replacement.Pham founded Cadrenal; he previously led Espero BioPharma as CEO and chairman and earlier worked as a partner at D+R LATHIAN.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cadrenal Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 03, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260603:nNDL8tJb5b:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","CVKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640490279","title":"Cadrenal Therapeutics to attend BIO International Convention 2026 partnering event","url":"https://stock-news.laohu8.com/highlight/detail?id=2640490279","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640490279?lang=en_us&edition=fundamental","pubTime":"2026-06-03 21:22","pubTimestamp":1780492946,"startTime":"0","endTime":"0","summary":"Cadrenal will attend the BIO International Convention 2026 Partnering Event in San Diego on June 22-25, 2026.Management plans partnering meetings to discuss development and commercialization options for CAD-1005, a Phase 3-ready 12-LOX inhibitor for HIT.Talks will also cover tecarfarin, a late-stage oral anticoagulant with FDA Orphan Drug and Fast Track designations in ESRD-AFib, LVAD patients.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cadrenal Therapeutics Inc. published the original content used to generate this news brief on June 03, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260603:nNDL3XfNht:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","CVKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640924722","title":"Cadrenal Therapeutics CEO, Chairman Quang X. Pham sells USD 3,057.57 in common shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2640924722","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640924722?lang=en_us&edition=fundamental","pubTime":"2026-06-03 08:34","pubTimestamp":1780446892,"startTime":"0","endTime":"0","summary":"Cadrenal Therapeutics CEO and Chairman Quang X. Pham sold 652 shares of common stock in late May and early June.Sales priced at USD 5.01 on May 29, 2026, USD 4.46 on June 2, 2026.Directly held stake fell to 181,509 shares following the June 2 sale.He also reported 200,000 shares held indirectly through The PVBQ Living Trust.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cadrenal Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 02, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260603:nNDL5nrs89:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Cadrenal Therapeutics CEO, Chairman Quang X. Pham sells USD 3,057.57 in common shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","CVKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639677513","title":"Cadrenal Therapeutics CEO, Chairman Quang X. Pham sells USD 69,363 of common shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2639677513","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639677513?lang=en_us&edition=fundamental","pubTime":"2026-05-30 04:33","pubTimestamp":1780086812,"startTime":"0","endTime":"0","summary":"Cadrenal Therapeutics CEO and Chairman Quang X. Pham sold 12,763 common shares in May at weighted-average prices of $4.93 to $5.76.Direct holdings fell to 182,161 shares following the latest sale on May 28.He also reported 200,000 shares held indirectly through The PVBQ Living Trust.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cadrenal Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 29, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260529:nNDL8Bt9rB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Cadrenal Therapeutics CEO, Chairman Quang X. Pham sells USD 69,363 of common shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CVKD","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638241355","title":"Cadrenal Therapeutics CEO, Chairman Quang Pham sells 1,165 common shares for $6,628.85","url":"https://stock-news.laohu8.com/highlight/detail?id=2638241355","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638241355?lang=en_us&edition=fundamental","pubTime":"2026-05-27 09:07","pubTimestamp":1779844041,"startTime":"0","endTime":"0","summary":"Cadrenal Therapeutics CEO and Chairman Quang Pham sold 1,165 common shares on May 22, 2026 at a weighted average USD 5.69.Direct holdings fell to 194,924 shares following the sale.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cadrenal Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 26, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260527:nNDL2xfdkj:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Cadrenal Therapeutics CEO, Chairman Quang Pham sells 1,165 common shares for $6,628.85","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CVKD","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636986424","title":"Cadrenal Therapeutics to present at Lytham Partners Spring 2026 Investor Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2636986424","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636986424?lang=en_us&edition=fundamental","pubTime":"2026-05-20 04:31","pubTimestamp":1779222711,"startTime":"0","endTime":"0","summary":"Cadrenal Therapeutics will present at the virtual Lytham Partners Spring 2026 Investor Conference on May 28, 2026.The webcast presentation is scheduled for 9:30 a.m. ET.Management will also hold virtual one-on-one investor meetings during the May 28 event.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260519:nNDL33BgQ5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4112","IE00B3QW5Z07.USD","IE00BN0W2W23.USD","BK4007","LU2210149790.SGD","CVKD","LU2210150020.SGD","LU2095319765.USD","IE00BGHQF748.EUR","SG9999014021.USD","BK4588","NDAQ","BK4585","IE00BKPKM429.USD","IE00B64PRP62.GBP","LU0314104364.USD","SG9999014039.USD","SG9999014013.SGD","IE00BN0W2T93.GBP","IE00BN0W2V16.EUR","SG9999014005.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633468381","title":"Cadrenal Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2633468381","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633468381?lang=en_us&edition=fundamental","pubTime":"2026-05-08 23:29","pubTimestamp":1778254197,"startTime":"0","endTime":"0","summary":"Cadrenal Therapeutics Inc reports results for the quarter ended March 31 - Earnings SummaryCadrenal Therapeutics Inc CVKD.OQ reported a quarterly adjusted loss of $1.04 per share for the quarter ended","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260508:nL8N41L1UR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","CVKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633142286","title":"Press Release: Cadrenal Therapeutics Reports First Quarter 2026 Financial Results and Provides Phase 3 Development Update on CAD-1005 Following End-of-Phase 2 Meeting with FDA","url":"https://stock-news.laohu8.com/highlight/detail?id=2633142286","media":"Dow Jones","labels":["productRelease","dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633142286?lang=en_us&edition=fundamental","pubTime":"2026-05-07 20:30","pubTimestamp":1778157000,"startTime":"0","endTime":"0","summary":"PONTE VEDRA, Fla., May 07, 2026  -- Cadrenal Therapeutics, Inc. , a late-stage biopharmaceutical company advancing novel therapies for life-threatening immune and thrombotic conditions, today reported its financial results for the first quarter ended March 31, 2026, and provided a corporate update highlighting continued progress in its CAD-1005 program for HIT. The Company has now received the official minutes from its End-of-Phase 2  meeting with the U.S. Food and Drug Administration , which provided guidance on key elements of the planned pivotal Phase 3 registration trial for CAD-1005, Cadrenal's investigational first-in-class 12-lipoxygenase  inhibitor being developed to treat suspected heparin-induced thrombocytopenia . Based on this feedback and Phase 2 data, Cadrenal plans to advance directly to a randomized, blinded, placebo-controlled Phase 3 study evaluating CAD-1005 added to standard-of-care anticoagulation in patients with HIT.-- Received official FDA EOP2 meeting minutes p","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK6096","LABU","BK6505","CVKD","N0Z.SI","BK4139","BK4539","BK4173","HIT","BK4007","LENZ","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632955244","title":"Cadrenal Therapeutics Inc  expected to post a loss of $1.62 a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2632955244","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632955244?lang=en_us&edition=fundamental","pubTime":"2026-05-04 21:11","pubTimestamp":1777900268,"startTime":"0","endTime":"0","summary":"Cadrenal Therapeutics Inc  expected to post a loss of $1.62 a share - Earnings Preview Cadrenal Therapeutics Inc CVKD.OQ CVKD.O is expected to  show no change in quarterly revenue when it reports  res","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260504:nL8N41H19E:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CVKD","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632903610","title":"Analysts’ Top Healthcare Picks: Pacira Pharmaceuticals (PCRX), Cadrenal Therapeutics, Inc. (CVKD)","url":"https://stock-news.laohu8.com/highlight/detail?id=2632903610","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632903610?lang=en_us&edition=fundamental","pubTime":"2026-05-01 21:51","pubTimestamp":1777643493,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Pacira Pharmaceuticals (PCRX), Cadrenal Therapeutics...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-pacira-pharmaceuticals-pcrx-cadrenal-therapeutics-inc-cvkd-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-pacira-pharmaceuticals-pcrx-cadrenal-therapeutics-inc-cvkd-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4581","LABU","CVKD","BK4137","XLV","BK4588","BK4585","LU0029874061.USD","PCRX","XBI","LU0128526141.USD","BK4007","HCSG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631555226","title":"Cadrenal Therapeutics completes CAD-1005 End-of-Phase 2 meeting with FDA","url":"https://stock-news.laohu8.com/highlight/detail?id=2631555226","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631555226?lang=en_us&edition=fundamental","pubTime":"2026-04-30 21:59","pubTimestamp":1777557561,"startTime":"0","endTime":"0","summary":"Cadrenal Therapeutics (CVKD) announced a regulatory milestone after completing its End-of-Phase 2 meeting with the FDA and receiving guidance on ke...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cadrenal-therapeutics-completes-cad-1005-end-of-phase-2-meeting-with-fda-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cadrenal-therapeutics-completes-cad-1005-end-of-phase-2-meeting-with-fda-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","BK4585","BK4588","LENZ","LABU","CVKD","BK4007","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631637812","title":"Cadrenal plans pivotal Phase 3 trial of CAD-1005 in heparin-induced thrombocytopenia","url":"https://stock-news.laohu8.com/highlight/detail?id=2631637812","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631637812?lang=en_us&edition=fundamental","pubTime":"2026-04-30 20:39","pubTimestamp":1777552743,"startTime":"0","endTime":"0","summary":"Cadrenal Therapeutics outlined pivotal Phase 3 plans for CAD-1005 in heparin-induced thrombocytopenia following an End-of-Phase 2 meeting with FDA.Phase 2 results were already presented, showing fewer clot-related complications when CAD-1005 was added to standard anticoagulant care.Planned randomized, blinded, placebo-controlled Phase 3 trial targets about 120 patients across up to 50 centers worldwide.Primary readout will assess whether CAD-1005 reduces new or worsening clot events in lab-confirmed cases.Program timeline points to a potential NDA submission in 2029.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260430:nNDL4VB1LZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","SG9999014013.SGD","NDAQ","IE00B64PRP62.GBP","LU2210150020.SGD","SG9999014021.USD","CVKD","IE00BKPKM429.USD","IE00B3QW5Z07.USD","LU2210149790.SGD","IE00BN0W2W23.USD","SG9999014005.SGD","LU2095319765.USD","IE00BN0W2T93.GBP","IE00BN0W2V16.EUR","BK4112","SG9999014039.USD","IE00BGHQF748.EUR","LU0314104364.USD","BK4007","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631632462","title":"Cadrenal Therapeutics Inc - FDA Provides Guidance for Phase 3 Advancement of CAD-1005 in Hit","url":"https://stock-news.laohu8.com/highlight/detail?id=2631632462","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631632462?lang=en_us&edition=fundamental","pubTime":"2026-04-30 20:30","pubTimestamp":1777552201,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260430:nTUA6VM1M9:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CVKD","BK4007"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":3,"totalSize":79,"code":"91000000","status":"200"}]}}